In addition, ZNF300 was downregulated during embryonic stem cell differentiation in vitro[15] and associated with 5q-syndrome, a distinct subtype of primary myelodysplastic syndrome (MDS) defined by interstitial deletion of chromosome 5q31-33 [16], [17]. Here, ZNF300 is linked to myelodysplastic syndrome.